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Abstract
In the present study, we developed a complete process to produce in insect cells a high amount of the ectodomain of rabies 
virus glycoprotein G  (GE) as suitable antigen for detecting anti-rabies antibodies. Using the baculovirus expression vector 
system in Sf9 insect cells combined with a novel chimeric promoter (polh-pSeL), the expression level reached a yield of 
4.1 ± 0.3 mg/L culture, which was significantly higher than that achieved with the standard polh promoter alone. The protein 
was recovered from the cell lysates and easily purified in only one step by metal ion affinity chromatography, with a yield 
of 95% and a purity of 87%. Finally,  GE was successfully used in an assay to detect specific antibodies in serum samples 
derived from rabies-vaccinated animals. The efficient strategy developed in this work is an interesting method to produce 
high amounts of this glycoprotein.
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Introduction
Rabies virus (RABV) is the etiologic agent of rabies, a glob-
ally distributed infectious disease that causes fatal encepha-
litis in mammals. RABV infection of livestock animals such 
as camelids, sheep, goats, and cows causes significant eco-
nomic losses in the productive system (Jibat et al. 2016). In 
addition, this disease also affects humans, causing approxi-
mately 59,000 deaths per year (Hampson et al. 2015).
RABV is a negative-stranded RNA virus that belongs to 
the genus Lyssavirus and family Rhabdoviridae. Among its 
structural proteins, the rabies virus glycoprotein G (RABV-
G) is the most antigenic and immunogenic surface protein 
involved in viral attachment (Wunner et  al. 1988). The 
mature RABV-G protein (MW 65 kDa) is formed by an 
external domain (ectodomain, 1-439 amino acid) exposed 
on the surface of the virus, a transmembrane domain (440-
461 amino acid), and a cytoplasmic domain (462-505 amino 
acid) (Huang et al. 2017). In particular, the ectodomain is 
responsible for the induction of anti-rabies antibodies in 
infected and vaccinated individuals (Perrin et al. 1985).
RABV infection is prevented through vaccination with 
the inactivated whole virus. Thus, there is a high demand 
for efficient and easy-to-handle methods to evaluate the 
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immunity state of immunized animals, based on the quan-
tification of anti-RABV-G antibodies (Wasniewski and Cli-
quet 2012). Several Enzyme-Linked ImmunoSorbent Assays 
(ELISAs) have been developed using the chemically inacti-
vated whole virus or pure glycoprotein G as the target anti-
gen (Cliquet et al. 2004; Feyssaguet et al. 2007). However, 
the use of the whole virus as the target antigen may produce 
non-specific reactions with other antibodies present in the 
serum sample. In addition, the purification process of a sub-
unit of RABV is complex, requiring specialized containment 
laboratories and a high amount of rabies virus (Zhang et al. 
2009). Thus, the use of recombinant RABV-G as a coating 
antigen to detect anti-rabies antibodies is an attractive tech-
nology that does not require of specialized facilities for virus 
manipulation (Qian et al. 2013). The full-length RABV-G 
has been expressed in diverse systems. In Escherichia coli, 
the RABV-G has been highly expressed as inclusion bod-
ies but found to lack its immunogenicity (Yelverton et al. 
1983), whereas in Saccharomyces cerevisiae, the same anti-
gen proved to be hyperglycosylated and incorrectly folded 
(Sakamoto et al. 1999). In the baculovirus expression vector 
system (BEVS), the full-length RABV-G has been expressed 
anchored to the plasma membrane of insect cells with cor-
rect folding and biological properties similar to those of 
the native protein (Tuchiya et al. 1992; Ramya et al. 2011). 
However, the expression of transmembrane proteins in 
BEVS is difficult and produces low yields (van Oers 2011). 
In addition, the solubilization and extraction of transmem-
brane proteins constitute a bottleneck in all expression sys-
tems, because protein structure is usually lost during puri-
fication. This loss can be avoided using certain extraction 
agents, which in turn might impair the purification process 
itself (Carpenter et al. 2008). For these reasons, the purifi-
cation processes of this kind of proteins are tedious, time-
consuming, and difficult to scale-up (Qoronfleh et al. 2003). 
Alternatively, it has been possible to produce a soluble form 
through the expression of the RABV-G ectodomain  (GE). 
The  GE has been expressed in several expression systems: 
mammalian cells (Gupta et al. 2005), insect Sf21 cells (Sis-
soëff et al. 2005), and yeast cells (Qian et al. 2013; Picotto 
et al. 2017). In all cases, the soluble protein expressed was 
antigenic and immunogenic, and could be used to detect the 
immunological status of vaccinated hosts. Among the differ-
ent expression systems available, insect cells present some 
advantages that support the choice of the BEVS platform 
for  GE production. For instance, the insect cells are easier 
to culture and more tolerant of osmolarity and by-product 
concentration than mammalian cells for large-scale protein 
(Ikonomou et al. 2003). In addition, BEVS offer a more 
suitable eukaryotic environment than yeast for glycoprotein 
production (Rendić et al. 2008). So far, the only work report-
ing the  GE expression in BEVS focused on  GE antigenic-
ity characteristics, but provided little information about the 
production and purification process (Sissoëff et al. 2005). 
The traditional promoters used to express the foreign protein 
in this system are polyhedrin (polh) and p10 (Martínez-Solís 
et al. 2019). However, alternative promoters have recently 
been developed to improve expression levels. Martinez Solís 
et al. (2016) designed a new strong chimeric promoter (polh-
pSeL) by combining the polh promoter and 120 nt belonging 
to the promoter from the orf46 of Spodoptera exigua mul-
tiple nucleopolyhedrovirus (pSeL). However, this promoter 
has not been tested for the expression of different proteins 
with therapeutic or industrial value.
In this work, we report for the first time a complete pro-
cess to produce, using standard as well as the novel pro-
moter, high amounts of purified  GE in Sf9 cells to obtain a 
suitable antigen for detecting anti-RABV Ig.
Materials and methods
Glycoprotein G cDNA sequence and cloning 
into a baculovirus vector
The detailed procedure for constructing the baculovirus vec-
tor is shown in Supplementary Fig. S1. The full-length gly-
coprotein G cDNA sequence from RABV CVS strain (Gen-
Bank Accession No. AJ506997.1) cloned into the pGEMT 
easy plasmid (Promega, Madison, USA) was kindly provided 
by Oscar Pérez (Servicio de Vacuna anti-rábica, Adminis-
tración Nacional de Laboratorios e Institutos de Salud “Dr. 
Carlos Malbrán”, Buenos Aires, Argentina). Using this vec-
tor as a template, the truncated glycoprotein G—composed 
only of the ectodomain  (GE) without its endogenous sig-
nal peptide from 58 bp to 1377 bp corresponding to amino 
acid residues 1-439 of the mature RABV-G—was amplified 
by PCR using two specific primers. These primers added 
BamHI and EcoRI restriction sites and six histidine resi-
dues (His-tag): 5′-CGGA TCC AAATT CCC TAT TTA CAC 
GAT ACC -3′ (Primer Sense; BamHI site underlined) and 
5′-CGA ATT CTC AGTGA TGA TGA TGA TGA TGA TAC 
TTC CCC CAG TTC GGG-3′ (Primer antisense, EcoR1 site 
underlined). The reverse primer included a sequence encod-
ing a His-tag (in bold). The PCR conditions (50 μL final vol-
ume) were as follows: 200 nM each primer, 1 × PFU buffer, 
0.3 mM each dNTP, and 2.5 U PFU polymerase (Promega). 
The PCR program was 95 °C for 6 min, 95 °C for 30 s, 56 °C 
for 30 s, and 72 °C for 1 min/kb × 30 cycles. An additional 
extension step of 72 °C for 5 min was then applied. After the 
reaction, the PCR product was purified using the PCR Wiz-
ardTM SV gel and PCR Clean-up System (Promega). The 
 GE sequence fused to the His-tag sequence was then cloned 
using the BamHI and EcoRI sites of the pAcGP67-B vector 
(BD Biosciences, San Diego, USA) to construct pAcGP67-
GE, which contained the nucleotide sequence that encode 
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the baculoviral glycoprotein 64 leader peptide (GP64; syn.: 
GP67). Using pAcGP67-GE as a template, the  GE fused with 
the GP64 signal peptide  (gpGE) was amplified following the 
protocol described above by PCR using two specific primers, 
which added the EcoRI and XbaI restriction sites: 5′-CGAA 
TTC ATG CTA CTA GTA A ATC AGT CAC-3′ (primer sense, 
EcoRI site underlined) and 5′- GTCT AGA TCA GTG ATG 
ATG ATG ATG ATG-3′ (primers antisense, XbaI site under-
lined). The  gpGE cassette and the enhanced green fluorescent 
protein (EGFP) cDNA were cloned into the pFastBacDual 
vector (Thermo Fisher Scientific, Waltham, USA) under the 
polh and p10 promoter, respectively. For this purpose, the 
EGFP (GenBank Accession No. NC_013179.1) sequence 
cloned into the pGEMT easy (Promega) plasmid was kindly 
provided by Dr Oscar Taboga (Centro de Investigaciones en 
Ciencias Veterinarias y Agronómicas, Instituto Nacional de 
Tecnología Agropecuaria, Buenos Aires, Argentina). Using 
this vector as a template, EGFP was amplified by PCR fol-
lowing the protocol described above using two specific prim-
ers, which added SmaI and NcoI restriction sites: 5′-GCCC 
GGG ATG GTG AGC AAG GGC GAGG-3′ (primer sense, 
SmaI site underline) and 5′-GCCA TGG GTC AGT ACA GCT 
CGT CCA TGC-3′ (primer antisense, NcoI site underline). 
The PCR product was then cloned into the pFastBacDual 
vector (ThermoFisher) to generate the EGFP-polh vector. 
Then, the  gpGE cassette was purified and cloned using the 
EcoRI and XbaI sites of the EGFP-polh vector to generate 
the EGFP-polh-gpGE construction. The vector combining 
two promoters (EGFP-polh-pSeL-gpGE) was constructed 
by modification of the EGFP-polh-gpGE vector. The polh-
pSel promoter fragment was obtained from the polh-pSeL-
GFP plasmid (Martínez-Solís et  al. 2016) by digestion 
with BstZ17I and EcoRI enzymes. Then, the fragment was 
inserted into the BstZ17I and EcoRI sites of the EGFP-polh-
gpGE vector, generating the EGFP-polh-pSeL-gpGE vector. 
All the DNA constructs were verified by Sanger sequencing.
Insect cell culture
The Spodoptera frugiperda (Sf9) insect cell line (Thermo 
Fisher Scientific) was maintained in suspension cultures in 
sterile Erlenmeyer and grown in Sf-900™ II SFM medium 
(Thermo Fisher Scientific) supplemented with 1% (V/V) 
antibiotic–antimycotic solution (Thermo Fisher Scientific) 
at 27 °C under continuous shaking at 100 rpm. Besides, the 
suspension volume did not exceed 10% of the total volume 
of the Erlenmeyer flask.
Virus production
The recombinant baculoviruses were obtained using 
the Bac to  Bac® baculovirus expression system 
(Thermo Fisher Scientific) following the manufacturer’s 
instructions. The EGFP-polh-gpGE and EGFP-polh-pSeL-
gpGE vectors were transformed in chemically competent E. 
coli DH10Bac™ strain (Thermo Fisher Scientific) by heat 
shock to generate the recombinant bacmid by transposi-
tion. Then, the bacmids were purified and used to transfect 
1 million Sf9 cells using Cellfectin II Reagent (Thermo 
Fisher Scientific). After a 3-day incubation at 27 °C, the 
cell culture supernatant was collected and centrifuged at 
500 ×g for 10 min. The transfection efficiency was deter-
mined by measuring EGFP expression by fluorescence 
under UV light. The recombinant AcMNPV baculoviruses 
polyhedrin-minus virus containing EGFP under the con-
trol of the p10 promoter and the  gpGE sequence under the 
control of the polh or polh-pSeL promoters were named 
Acpolh-GE and Acpolh-pSeL-GE, respectively (Fig. 1). 
Following three amplification steps, the virus titer was 
determined by a plaque assay (O´Reilly et al. 1994). The 
amplified virus stock was used for producing the recom-
binant protein in further experiments.
Insect cell infection
For the  GE expression assay, independent Sf9 suspension 
cultures in log phase at a cell density of 1 ×  108 cells in 
50 mL were infected with Acpolh-pSeL-GE or Acpolh-GE 
at a multiplicity of infection (MOI) of 0.1, 1, and 5. The 
infected suspension culture was incubated in an orbital 
shaker at 100 rpm in the dark at 27 °C for 4 days. To study 
the expression at different days post-infection (dpi), sam-
ples of 1 mL were collected each day. The culture super-
natant was separated from the cell by centrifugation at 
500×g for 10 min. The pellet and the supernatant were 
stored at − 20 °C until further experiments. For SDS-
PAGE and western blot analysis, the culture supernatant 
was assessed without any extra treatment, while the cell 
pellet was treated as indicated in the following section 
to obtain total protein extract. An Sf9 suspension culture 
infected with baculovirus AcMNPVHRPC—previously 
constructed in our laboratory—was also included as a 
control (Targovnik et al. 2010).
Total protein extraction from infected cells
The cell pellet was resuspended in lysis buffer (50 mM Tris/
HCl pH 8.0, 300 mM NaCl, and 1% [v/v] NP-40) with a 
protease inhibitor cocktail (Sigma-Aldrich, Saint Louis, 
USA) by adding 100 μL of lysis buffer per 2 ×  106 cells. 
After incubation at 4 °C for 30 min, the cellular debris was 
separated by centrifugation at 10,000×g at 4 °C for 10 min. 
The pellet was discarded, and the supernatant was stored 
at − 20 °C until further experiments.
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Total protein measurement
Total protein concentration was determined by following the 
Bradford microassay protocol (Bradford 1976) with bovine 
serum albumin (BSA) as the standard, using the Quick 
Start™ Bradford reagent (Bio-Rad, Hercules, USA).
Electrophoretic analysis
The protein samples were resolved by SDS-PAGE on 12.5% 
or 15% polyacrylamide gels. The samples were heated at 
100  °C for 5 min in sample buffer (125 mM Tris/HCl, 
pH 6.8, 4% [w/v] SDS, 20% [w/v] glycerol, 0.01% [w/v] 
bromophenol blue, and 10% [v/v] 2-mercaptoethanol). The 
resulting gels were stained with Coomassie Blue R-250. 
For western blot analysis, the gels were transferred onto a 
nitrocellulose membrane (GE Healthcare, Chicago, USA) 
and  GE was detected using a hyperimmune rabbit serum 
against rabies whole inactivated virus in a 1/1500 dilution 
as the primary antibody and horseradish peroxidase-con-
jugated mouse anti-rabbit IgG (H + L) (Sigma-Aldrich) in 
a 1/1500 dilution as the secondary antibody. Also,  GE was 
detected using a mouse anti-His antibody (BD Biosciences) 
in a 1/3000 dilution as the primary antibody and horserad-
ish peroxidase-conjugated goat anti-mouse IgG (H + L) 
(DAKO, Copenhagen, Denmark) in a 1/1000 dilution as the 
secondary antibody. The development was carried out with 
an enhanced chemiluminescence substrate (Thermo Fisher 
Scientific) and high-performance chemiluminescence film 
(Thermo Fisher Scientific).
GE purification by immobilized metal ion affinity 
chromatography (IMAC)
The cell pellet from 50 mL of cell culture infected with 
Acpolh-gpGE, Acpolh-pSel-gpGE, or AcMNPVHRPC 
(baculovirus control) was resuspended and lysed in chro-
matographic equilibration buffer (50 mM Tris/HCl pH 8.0, 
300 mM NaCl, 40 mM imidazol, and 10% (v/v) glycerol) 
with 1% (v/v) NP-40, protease inhibitor cocktail without 
EDTA (Sigma-Aldrich) and 100 U/mL deoxyribonuclease I 
(Sigma-Aldrich). Then, 1 mL of the buffer was used for 6.5 
×  106 cells (Klaus et al. 2015). The lysates were incubated 
at 4 °C for 30 min and centrifuged at 10,000×g at 4 °C for 
10 min. The soluble fraction was loaded on the 1 mL His-
Trap column (GE Healthcare), equilibrated with the same 
buffer. Following a washing step with equilibration buffer 
containing 100 mM imidazol, an elution step was performed 
by increasing the imidazole concentration to 500 mM. The 
linear flow rate was 0.4 cm/min, and 1.5 mL fractions were 
collected. Protein separation was monitored by absorbance 
at 280 nm. All fractions were collected and analyzed by 
SDS-PAGE and western blot. The same process was used 
for Sf9 cells infected with the control virus. For image pro-
cessing, the gels were scanned and then analyzed with the 
ImageJ software (National Institute of Health, USA). The 
Fig. 1  a Recombinant baculovirus for the expression of  GE under the 
polh (Acpolh-GE) and polh-pSeL (Acpolh-pSeL-GE) promoters. GP64: 
viral secretion signal GP64; His-tag: six histidine tag. b Analysis of 
recombinant  GE localization in supernatants and cell pellets by west-
ern blot. Sf9 cells were infected with Acpolh-GE or Acpolh-pSeL-GE 
at MOI 5. At different days post-infection, the culture medium and 
infected Sf9 cells were harvested and analyzed. Western blot devel-
oped with mouse anti-His antibody. Line S1–S4: culture supernatant 
from 1 to 4 days post-infection; P1–P4: cell pellet from 1 to 4 days 
post-infection; polh-GE:  GE expression under the polh promoter; 
polh-pSeL-GE:  GE expression under the polh-pSeL promoter
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amount and purity of  GE were assessed by densitometric 
analysis of the band intensities from the SDS-PAGE and 
confirmed by ELISA and Bradford assay. The results are 
expressed as the mean ± standard deviation of at least three 
determinations from independent experiments.
Characterization of the expressed  GE by confocal 
microscopy
For confocal microscopy, 8×104 Sf9 cells were seeded into 
Lab-Tek Chambered coverglass dishes (Thermo Fisher Sci-
entific) and infected with the Acpolh-pSel-gpGE or Acpolh-
gpGE virus. The cells were incubated at 27 °C for 72 h, 
washed with PBS, and fixed in 4% paraformaldehyde (pH 
7 in PBS) for 15 min. Then, the cells were washed twice 
with PBS-T (PBS-0.05% Tween) and permeabilized with 
0.2% Triton X-100 for 30 min, or only washed twice with 
PBS. The permeabilized cells were subsequently washed 
twice with PBS-T and all the samples were treated with 1% 
BSA (Sigma-Aldrich) in PBS for 1 h. Next, the cells were 
incubated with a mouse anti-His antibody (1:100) (BD Bio-
sciences) in 1% BSA for 60 min and washed twice with 
PBS-T to remove nonspecifically bound antibody. The cells 
were incubated with Cy™3 AffiniPure Donkey Anti-Mouse 
IgG (H + L) antibody (1:800) (Jackson ImmunoResearch, 
West Grove, USA) in 1% BSA for 60 min, washed twice 
with PBS-T, and incubated for 10 min with TO-PRO-3 
Stain (1:300) (Thermo Fisher Scientific). Finally, the cells 
were washed three times with PBS-T and once with distilled 
water, before they were mounted in ProLong Gold antifade 
reagent (Thermo Fisher Scientific). Samples were visualized 
in a Leica TCS-SP5 spectral laser confocal microscope.
Quantification of  GE expression by sandwich ELISA 
assay
MaxiSorp microplates (Sigma-Aldrich) were coated with 
100 μl of a mouse monoclonal anti-His antibody (1:1500) 
(BD Biosciences) in 1% non-fat dry milk overnight at 4 °C. 
The plates were washed with PBS-T and blocked with block-
ing buffer (PBS-T and 3% non-fat dry milk) for 1 h at RT. 
The plates were then washed with PBS-T and incubated 
with 100 μl of sample diluted 1/4 in sample diluent (same 
as blocking buffer) for 1 h at RT. Plates were then washed 
with PBS-T and incubated with 100 μl of hyperimmune 
rabbit serum against rabies whole inactivated virus diluted 
1/500 in sample diluent for 1 h at RT. Next, the plates were 
washed with PBS-T and incubated with 100 μl horserad-
ish peroxidase-conjugated mouse anti-rabbit IgG (H + L) 
(Sigma-Aldrich) in a 1/2000 dilution as the secondary anti-
body. The plates were washed again, and the colorimetric 
reaction was developed by adding 100 μL of TMB substrate 
(Thermo Fisher Scientific). After a 5-min incubation period 
at room temperature in the dark, color development was 
stopped by adding 50 μL of 4 N  H2SO4. Optical densities 
(OD) were measured at 450 nm. The amount of recombinant 
 GE expressed in different experiments was estimated with 
a standard curve of  GE (6 to 0.2 µg/ml) previously purified 
from Sf9-infected cells and quantified by gel densitometry 
and Bradford Assay. A sample from Sf9 cells infected with 
baculovirus control was also included as a negative control. 
The results are expressed as the mean ± standard deviation 
of at least three determinations. The results were statistically 
analyzed by two-way ANOVA followed by Bonferroni’s 
post hoc test using GraphPad Prism 5 software (GraphPad 
Software Inc., San Diego, USA). A p < 0.05 was considered 
statistically significant.
Mass spectrometry analysis
A purified protein sample was separated by SDS-PAGE on 
12% polyacrylamide gels and stained with colloidal Coomas-
sie Blue. The band corresponding to the molecular weight 
of  GE was cut off and in-gel-digested with trypsin, and the 
peptides were separated by HPLC (Easy-nLC 1000, Thermo 
Fisher Scientific), using a reverse-phase column (EASY-
Spray Column P/N ES80, Thermo Fisher Scientific) and 
analyzed by ESI-Orbitrap mass spectrometry (Q-Exactive, 
Thermo Fisher Scientific) with the software Proteome Dis-
coverer version 1.4 (Thermo Fisher Scientific).
Glycosylation assay
The purified  GE was subjected to N-glycosidase F (Roche, 
Mannheim, Germany) digestion. For this purpose, 14 μg 
of protein was mixed with 80 μL denaturing buffer (SDS 
2.5%, DTT 0.4 M). After heating at 100 °C for 10 min, the 
reaction buffer was added (0.05 M sodium phosphate buffer 
–PBS, pH 7.5, containing 1% (v/v) NP-40, Inhibitor cock-
tail protease and 3 U N-glycosidase F. As a control, 14 μg 
of denatured protein was incubated in the reaction buffer 
without enzyme. After incubation at 37 °C for 16 h, the 
sample was analyzed by SDS-PAGE and western blot, as 
described above.
Reactivity of RABV vaccinated llama sera to  GE 
protein by ELISA
Serum samples from vaccinated llamas were tested for 
the detection of anti-RABV Ig antibodies using MaxiSorp 
microplates (Sigma-Aldrich) coated with 0.5 μg of purified 
recombinant  GE. The plates were washed with PBS-T and 
blocked with blocking buffer (PBS-T and 3% non-fat dry 
milk) overnight at 4 °C. The plates were then washed with 
PBS-T and incubated with 100 μL of sera diluted 1/100 in 
sample diluent (same as blocking buffer) at 37 °C for 1 h. 
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The plates were then washed with PBS-T and incubated 
with 100 μl of horseradish peroxidase-conjugated rabbit 
anti-llamas Ig (Bethyl, Montgomery, USA) diluted 1/5000 
in sample diluent for 1 h at 37 °C. The plates were washed 
again and the colorimetric reaction was developed by add-
ing 100 μL of TMB substrate (Thermo Fisher Scientific). 
After a 10-min incubation period at room temperature in 
the dark, color development was stopped by adding 50 μL 
of 4 N  H2SO4. Optical densities (OD) were measured at 
450 nm. All determinations were performed in triplicate and 
the results are expressed as the mean ± standard deviation. 
The data obtained provided a cut-off value for further clas-
sification of each sample as positive/negative, for additional 
correlation with the vaccination status of each animal. The 
samples used in the analysis were from a llama serum bank 
belonging to Facultad de Farmacia y Bioquímica, Univer-
sidad de Buenos Aires. They were obtained during an anti-
rabies vaccination campaign with a second-generation rabies 
vaccine (derived from the culture supernatant of infected 
BHK cells).
Results and discussion
Generation of the recombinant baculoviruses 
Acpolh‑gpGE and Acpolh‑pSeL‑gpGE
The  GE sequence fused to the GP64 viral signal peptide and 
a His-tag  (gpGE) was cloned under the control of the polh 
promoter to obtain the EGFP-polh-gpGE vector. The GP64 
signal peptide would ensure post-translational modification 
and target the recombinant protein for secretion, whereas the 
addition of a C-terminal His-tag would facilitate the puri-
fication step of the glycoprotein by IMAC. In addition, the 
vector had the coding sequence of the EGFP protein cloned 
under the p10 promoter as a reporter gene to allow us to 
visualize the viral infection. To produce large quantities of 
 GE, the polh promoter was replaced with the polh-pSeL pro-
moter to obtain the polh-pSeL-gpGE vector (Supplementary 
Fig. S1). Plasmids were used to produce the corresponding 
bacmids. Transfection of the bacmids and amplification in 
Sf9 cells allowed us to obtain the Acpolh-GE and the Acpolh-
pSeL-GE viruses (Fig. 1a).
GE expression and localization in Sf9 cells
To determine  GE expression and localization in insect cell 
cultures, we infected Sf9 cells with Acpolh-GE or Acpolh-
pSeL-GE. We analyzed the culture supernatant and cell pel-
lets by western blot (Fig. 1b). The expression was evaluated 
up to 4 dpi to avoid high cell lysis that could affect the fol-
lowing purification step. Although the protein was expressed 
under the GP64 viral signal peptide, the system failed to 
secrete the protein. The protein was detected in the cell pel-
let (Fig. 1b). For this reason, the cells were lysed using a 
buffered detergent solution. The non-ionic detergent NP-40 
contributed to the cell lysis without affecting the protein 
structure, and its presence was essential for the total solubi-
lization of  GE. It was not necessary to add EDTA to stabilize 
membrane proteins in solution and dimethylsulfoxide to gen-
erate pores on the lipid membrane. Thus,  GE may be more 
weakly associated with the membrane than the full version.
The localization of  GE expressed under polh and polh-
pSeL was confirmed by immunofluorescence assay devel-
oped with a specific antiserum against the His-tag. As 
shown in Fig. 2,  GE was associated with the cell membrane, 
although its transmembrane region was removed, whereas 
EGFP was located throughout the cytoplasm. In addition, 
TO-PRO 3 fluorescent dye stained the nucleus of infected 
Sf9 cells. The results indicate that the His-tag were correctly 
exposed, since the antibodies were able to detect them in 
the native protein inside the cells, an important fact for the 
following purification step by IMAC.
The insect cell machinery is often overwhelmed due to 
the production of high levels of recombinant protein (Dalton 
and Barton 2014). The problem is exacerbated by the shut-
down of cell protein synthesis during the baculovirus infec-
tion (Urtasun et al. 2015). Thus, recombinant  GE might be 
trapped inside the cell due to insufficient cellular resources 
for their secretion into the culture medium (Steele et al. 
2017). In addition, the translocation of  GE to the extracel-
lular medium might be affected by its own physicochemical 
characteristics and by the absence of a proper protein traf-
ficking system in the heterologous expression host (Ashi-
kawa et al. 2011).
Previous studies have shown inefficient secretion of some 
other recombinant glycoproteins produced by BEVS (Klaus 
et al. 2015; Trabucchi et al. 2019). However, the fact that the 
expressed protein remained inside the cells did not affect its 
production and recovery.
Optimization of  GE expression and assessment 
of the potential improvement using the dual 
promoter
To determine the best conditions to produce the recombi-
nant protein (MOI, dpi, promoter) and compare the polh-
pSeL promoter activity with the standard polh promoter, 
we infected Sf9 cells with Acpolh-GE or Acpolh-pSeL-GE at 
MOIs of 0.1, 1, and 5, and analyzed the culture cell pellets 
at different dpi by sandwich ELISA (Fig. 3). The expression 
kinetics showed that the  GE expression increased gradually 
from 2 dpi, achieving a maximal expression level at 4 dpi for 
MOI 1 and 3 dpi for MOI 5. The expression level achieved 
at MOI 0.1 was lower than that of the other MOIs exam-
ined. The polh-pSeL promoter showed higher activity for the 
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expression of  GE than the polh promoter alone in most condi-
tions analyzed. The biggest difference in  GE expression was 
detected at MOI 5 and 3 dpi, where the yield achieved under 
the polh-pSeL promoter was 100% higher (4.0 ± 0.3 mg/L 
culture; 40 μg/2 ×  107 cells) than that achieved with the polh 
promoter alone (2.0 ± 0.2 mg/L culture; 20 μg/2 ×  107 cells). 
However, the same expression level reached under the polh-
pSeL promoter at MOI 5 and 3 dpi was detected at lower 
MOI, often necessary for large-scale protein production. 
When the cell culture was infected at MOI 1, the expression 
level under the polh-pSeL was maximal at 4 dpi, reaching 
a yield of 4.1 ± 0.3 mg/L culture (41 μg/2 ×  107 cells), the 
Fig. 2  Confocal microscopy 
analysis of  GE-expressing Sf9 
cells. a Bright Field image of 
infected Sf9 cells. b, f Infected 
Sf9 cells expressing  GE incu-
bated with a mouse anti-His 
monoclonal antibody and then 
with Cy™3 AffiniPure Donkey 
Anti-Mouse IgG (H + L) 
antibody. c Infected Sf9 cells 
expressing EGFP. d TO-PRO-
3-stained cells. e Overlay of 
TO-PRO-3- and Cy™3-stained 
cells. a–e: Sf9 cells infected 
with Acpolh-pSeL-GE; f: Sf9 
cells infected with Acpolh-GE
Fig. 3  Expression kinetics of  GE expressed under control of polh 
(white column) and polh-pSeL (gray column) promoters. Sf9 cells 
were infected at MOIs 0.1, 1, and 5 with Acpolh-pSeL-GE or Acpolh-
GE. At different days post-infection, the infected cells were harvested, 
lysed and analyzed by ELISA. Data are shown as mean ± stand-
ard deviation from three independent experiments. Columns with 
an asterisk were significantly different. * p < 0.05; **p < 0.005; 
***p < 0.001
 3 Biotech           (2019) 9:385 
1 3
 385  Page 8 of 11
expression being 46% higher than that achieved with the 
polh promoter alone (2.8 ± 0.2 mg/L culture; 28 μg/2 ×  107 
cells). After the expression, no significant difference in the 
final titre reached for Acpolh-GE and Acpolh-pSeL-GE was 
found (⁓1 ×  108 UFP/ml), suggesting that the expression dif-
ference is not influenced by the virus replication. In addition, 
the yield of  GE achieved in Sf9 was higher than that reached 
for full-length RABV-G expression in High  Five® (Ramya 
et al. 2011) cells under the polh promoter (1.78 μg/2 ×  107 
cells) using four times less virus.
Therefore, for further purification experiment, we 
selected the optimized culture parameters (MOI 1 and 4 
dpi) and the polh-pSeL promoter to produce  GE in Sf9 cells.
The polh-pSeL promoter was developed to improve the 
expression of GFP in insect cells (Martínez-Solís et al. 
2016). However, this novel promoter had not been assayed to 
produce other recombinant proteins and had not been tested 
in Sf9 insect cell lines. Thus, we describe, for the first time, 
the use of the polh-pSeL promoter to enhance the expression 
level of a protein of diagnostic interest in Sf9 insect cell line.
Purification of  GE from Sf9 cells
IMAC was performed to purify the  GE from lysates of Sf9 
cells. The fact that the cells were cultured in a medium with-
out fetal bovine serum facilitated the purification step, thus 
reducing the contaminants in the sample. After the sample 
was loaded into the column,  GE was adsorbed on the matrix 
with high affinity due to the presence of the exposed His-tag, 
confirmed previously by the immunofluorescence assay and 
western blot. Fortunately, the protein was recovered only 
in the elution fraction by addition of 500 mM imidazole 
(Fig. 4). Most contaminating proteins, including EGFP, 
appeared in the flow through (i.e., not adsorbed) and the 
addition of 40 mM imidazole to the equilibration buffer 
and the washing step with 100 mM imidazole enhanced 
the purity of  GE (Fig. 4a). Figure 4 shows the correspond-
ing SDS-PAGE (Fig. 4a) and western blot pattern (Fig. 4b) 
of the final product compared to the starting material. The 
purified  GE was correctly detected by western blot using a 
hyperimmune rabbit serum against rabies whole inactivated 
virus. After the purification step, it was possible to obtain a 
4.0 ± 0.1 mg/L culture with a yield of 95% and a purity of 
87% (Table 1). In addition, the highest activity of the polh-
pSeL versus polh promoter for the expression of  GE was also 
confirmed by gel densitometry after IMAC purification step 
(Fig. 4c).
Characterization of the purified  GE
The mass spectrometry analysis of the purified protein after 
trypsin treatment showed that the 15 peptides obtained per-
fectly matched those predicted for  GE, thus confirming the 
identity of the recombinant protein with a coverage of 49% 
(Supplementary Table 1).
To further characterize the purified  GE, it was treated with 
N-glycosidase F digestion (Fig. 5). The MW of the protein 
of around 53 kDa (Fig. 4a) was larger than sequential weight 
theoretically predicted of 50 kDa, taking into account the 
His-tag (Gasteiger et al. 2005). It has been reported that 
 GE has three potential N-glycosylation sites and that only 
two of them are efficiently glycosylated in virions (Shakin-
Eshleman et al. 1992). After cleavage, the molecular weight 
of the glycoprotein decreased to about 50 kDa. Thus, this 
evidence suggests that the N-glycosylation is responsible for 
the differential size between the digest and undigested  GE.
Even though the secretion pathway could be function-
ally affected during baculovirus infection in insect cells, the 
BEVS is capable of producing glycosylated protein using 
very late baculoviral promoters such as polh (Metz et al. 
2011; Targovnik et al. 2010). For instance, when the full-
length RABV-G was expressed in High  Five® cells under 
the polh promoter, it was possible to obtain a glycosylated 
protein anchored to the plasma membrane (Ramya et al. 
2011). In addition, viral proteins are glycosylated by the host 
cell during the infection (Stiles and Wood 1983). To avoid 
Fig. 4  IMAC purification of  GE expressed under the polh-pSeL (a–c) 
and polh (c) promoters. a SDS-PAGE analysis of fraction collected 
during purification process. b Western blotting analysis of fraction 
collected during purification process using rabbit anti-RABV poly-
clonal antibody. c SDS-PAGE analysis and quantification of puri-
fied  GE expressed under control of polh and polh-pSeL promoters at 
MOI 1 and harvested at 4 dpi. Lane M protein marker, T total protein 
extract, FT flow through, W washing step (equilibration buffer with 
100 mM imidazole); E1, E2: IMAC fraction eluted by 500 mM imi-
dazole
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further cell damage and ensure higher quality post-transla-
tional modification, protein expression is usually restricted 
to more o less 3 dpi (Steele et al. 2017). Different degrees of 
success in glycosylation have been achieved depending on 
the protein expressed (Toth et al. 2011). In the present work, 
the results suggest that  GE moved successfully through the 
secretory pathway undergoing the expected glycosylation 
and were then anchored to plasma membrane for the possible 
reasons described above.
Use of  GE to detect anti‑RABV Ig in serum samples 
from vaccinated llamas
The breeding of South American camelids has become an 
extended practice. In South America, llamas have been con-
sidered one of the most outstanding breed animals for the 
last 30–40 years. This species has been reported to suffer 
from many infectious diseases such as rabies, which causes 
considerable economic loss (Friedrich et al. 2014). For this 
reason, we finally studied the use of the recombinant  GE 
to detect anti-RABV Ig in serum samples from vaccinated 
llamas. Therefore, multiwell plates were coated with 0.5 μg 
of purified  GE and the serum from llamas vaccinated or not 
with different RABV vaccines was tested. As a control, the 
elution purification fraction from Sf9 cells infected with con-
trol baculovirus was used to coat another plate and evalu-
ate whether the contaminant that remained in the purified 
 GE reacted with the Ig from RABV. Fortunately, only when 
the plates were coated with  GE, the reaction was specific, 
and this test was able to detect Ig from RABV, correctly 
differentiating the vaccinated animals (Fig. 6). This sug-
gests that  GE was correctly folded and enough to detect Ig 
in serum samples and that the kind of glycan structure typi-
cal of insects did not affect its antigenicity. In addition, the 
purity achieved by IMAC was adequate to develop the assay. 
Therefore, 1 L of cell culture was enough to produce around 
83 plates of 96 wells. The assay developed in this work was 
suitable for a fast evaluation of the effect of vaccination in 
animals.
Conclusions
We developed a complete process for producing large 
amounts of the  GE in Sf9 cells. Although the system failed 
to secrete this protein, it was possible to recover it from 
inside the cell and purify it in only one step by IMAC. In 
addition, we validated the new chimeric polh-pSeL promoter 
by expressing a protein of diagnostic interest. The  GE yield 
obtained using the polh-pSeL promoter was significantly 
higher than that obtained using the standard strong pro-
moter polh. This has opened the possibility to extend the use 
of this novel promoter for expressing commercially relevant 
Table 1  Purification process 
of  GE from Sf9 cells expressed 
under pol-pSeL promoter by 
IMAC
I crude extract before purification, II IMAC fraction eluted by 500 mM imidazole.  GE purification process 
determined by ELISA and Bradford assay
Step Volume (ml) GE (mg) Total protein 
(mg)
Purity (%) Yield (%) Purifi-
cation 
(Fold)
I 50 0.21 20.55 1.02 100 1
II 3 0.20 0.23 87 95 85
Fig. 5  GE glycosylation analysis. N-glycosidase F-mediated in  vitro 
deglycosylation of purified  GE. Western blot developed with mouse 
anti-His antibody. Line  GE: Purified  GE;  GE + PNGase F: Purified  GE 
treated with N-glycosidase
Fig. 6  Evaluation of the immunoreactivity of  GE to detect RABV 
antibody in serum samples from llamas. Control: serum from unvac-
cinated llamas; Vaccinated: serum from llamas vaccinated with a sec-
ond-generation RABV vaccine
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proteins in the future using the BEVS. The results allow us 
to conclude that the platform is an interesting alternative 
engineering approach to produce this recombinant protein 
as an antigen for the future development of a diagnostic test 
for rabies.
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